The European Medicines
Agency’s Pharmacovigilance Risk
Assessment Committee (PRAC),
has issued cautions on the use of
cancer therapy Iclusig (ponatinib)
and meds containing acipimox.
CLICK HERE for full details.The above article was sent to subscribers in Pharmacy Daily's issue from 11 Nov 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Nov 13
THE vaping reforms bill passed in the Senate this week has raised significant questions around pharmacy insurance premiums, business risks and regulatory compliance for community pharmacists, according to the profession’s peak body.
A COMBINATION of varenicline and nicotine lozenges may be a more effective treatment option for people looking to quit smoking compared to varenicline alone, according to results from a new clinical trial at Monash University.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.